MARKETS

BSE Prices delayed by 5 minutes... Prices as on Mar 20, 2019   ABB India 1336.15 [ 1.50% ]ACC 1557.65 [ -0.44% ]Ambuja Cements Ltd. 227.9 [ -0.83% ]Asian Paints Ltd. 1454.95 [ 0.07% ]Axis Bank Ltd. 755.55 [ -0.72% ]Bajaj Auto Ltd. 2948.1 [ -1.08% ]Bank of Baroda 125.25 [ 0.76% ]Bharti Airtel 333.75 [ -0.86% ]Bharat Heavy Ele 68.6 [ 0.73% ]Bharat Petroleum 389.05 [ -4.56% ]Britannia Ind. 3092.1 [ -1.03% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 533.1 [ 0.02% ]Coal India 237.2 [ -2.43% ]Colgate Palm. 1292.4 [ 0.33% ]Dabur India 426.05 [ -0.15% ]DLF Ltd. 199.3 [ 2.60% ]Dr. Reddy's Labs 2747.25 [ 1.58% ]GAIL (India) Ltd. 354.15 [ -2.32% ]Grasim Inds. 818.15 [ -0.22% ]HCL Technologies 1039.25 [ 0.45% ]HDFC 1987.15 [ 0.98% ]HDFC Bank 2299.2 [ 1.39% ]Hero MotoCorp 2612.45 [ -0.11% ]Hindustan Unilever L 1689.2 [ -0.61% ]Hindalco Indus. 206.6 [ 2.05% ]ICICI Bank 393 [ -1.29% ]IDFC L 44.45 [ -0.56% ]Indian Hotels Co 148.5 [ -0.97% ]IndusInd Bank 1714.4 [ -0.65% ]Infosys 738.5 [ 2.36% ]ITC Ltd. 298.5 [ -0.30% ]Jindal St & Pwr 164.45 [ -2.66% ]Kotak Mahindra Bank 1350.9 [ 0.20% ]L&T 1372.85 [ 1.19% ]Lupin Ltd. 752.55 [ -0.36% ]Mahi. & Mahi 679.9 [ -1.39% ]Maruti Suzuki India 6680.8 [ -2.22% ]MTNL 12.97 [ -3.06% ]Nestle India 10534.95 [ -1.33% ]NIIT Ltd. 91 [ 0.78% ]NMDC Ltd. 113.7 [ -3.60% ]NTPC 129.3 [ -4.29% ]ONGC 151.85 [ -3.28% ]Punj. NationlBak 93.55 [ 3.37% ]Power Grid Corpo 197.45 [ -0.63% ]Reliance Inds. 1375.6 [ 0.03% ]SBI 303.45 [ 0.23% ]Vedanta 174.15 [ 0.84% ]Shipping Corpn. 36.6 [ -2.79% ]Sun Pharma. 474.35 [ 1.07% ]Tata Chemicals 585.85 [ -1.02% ]Tata Global Beverage 198 [ -2.73% ]Tata Motors Ltd. 179.85 [ -1.61% ]Tata Steel 513.55 [ -2.41% ]Tata Power Co. 72 [ -1.37% ]Tata Consultancy 2015.5 [ -0.45% ]Tech Mahindra Ltd. 789.85 [ -0.59% ]UltraTech Cement 3928.85 [ -1.31% ]United Spirits 571 [ -0.76% ]Wipro Ltd 261.55 [ 1.53% ]Zee Entertainment En 443.25 [ -4.99% ]

News Details

You can view in detail.
Zydus Cadila gets USFDA nod to market generic Sitagliptin and Metformin Hydrochloride 14/03/2019 16:48

Drug firm Zydus Cadila on Thursday said it has received tentative nod from the US health regulator to market generic Sitagliptin and Metformin Hydrochloride extended-release tablets used for controlling blood sugar levels.

The company has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Sitagliptin and Metformin Hydrochloride extended-release tablets in the strength of 50 mg/500 mg, 50 mg/1,000 mg and 100 mg/1,000 mg

The product is the generic version of Janumet XR tablets, it added.

The tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said.

The product contains two oral anti-diabetic medications used in the management of type 2 diabetes, it added.

The group now has 255 approvals and has so far filed over 350 abbreviated new drug applications (ANDAs) since the commencement of its filing process, Zydus Cadila said.

LOAD MORE